#Gene Synthesis Market Growth

[health-views-updates]

Gene Synthesis Market Growth Outlook: Size, Revenue & Demand 2024-2032

The Gene Synthesis Market Revenue was valued at USD 2.28 billion in 2023 and is forecasted to achieve remarkable growth, reaching USD 9.64 billion by 2032. The market is expected to register a robust CAGR of 17.41% during the forecast period of 2024-2032. The increasing adoption of gene synthesis technologies in research, diagnostics, and therapeutic applications is a primary driver of this exponential growth.

Key Drivers of Market Growth

The burgeoning demand for synthetic genes in various fields such as biotechnology, pharmaceutical development, and personalized medicine has significantly propelled the gene synthesis market. Researchers and healthcare providers are leveraging advancements in gene synthesis technologies to accelerate drug discovery, develop precision therapies, and address complex genetic disorders.

Furthermore, the integration of cutting-edge technologies, such as artificial intelligence (AI) and machine learning (ML), into gene synthesis processes has enhanced accuracy, reduced production costs, and minimized turnaround times. Additionally, the rising adoption of CRISPR-based gene-editing tools is creating a synergistic effect, boosting the market's expansion.

Governments and private investors worldwide are increasing funding in genomics research and synthetic biology, further fueling the development of the gene synthesis market. As a result, the industry is experiencing heightened innovation and an influx of new market players.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/4521

Regional Insights

North America currently holds a significant share of the gene synthesis market, attributed to its well-established healthcare infrastructure, increased R&D investments, and the presence of leading biotechnology firms. Meanwhile, the Asia-Pacific region is poised for rapid growth due to the increasing focus on genomics, rising healthcare expenditures, and supportive government initiatives aimed at fostering biotechnological advancements.

Market Outlook

The future of the gene synthesis market looks highly promising, with technological innovations driving the emergence of automated platforms, cloud-based solutions, and highly scalable synthesis processes. As the demand for personalized medicine and targeted therapies continues to rise, gene synthesis technologies will play an integral role in shaping the future of healthcare.

About Us

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us

Akash Anand – Head of Business Development & Strategy Email: info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[marketspace360]

Gene Synthesis Market| Manufacturers, Regions, Type and Application, Forecast by 2029

[market-insider]

Gene Synthesis in Therapeutics and Biopharmaceuticals: Market Trends and Growth Outlook

Gene synthesis refers to the artificial construction of genes using chemical synthesis methods, rather than relying on natural DNA replication processes. It involves assembling nucleotides, the building blocks of DNA, in a specific order to create a desired gene sequence. Gene synthesis has become a powerful tool in molecular biology and biotechnology, enabling scientists to design and engineer genes with precise sequences for various applications. In gene synthesis, the desired gene sequence is typically designed on a computer using bioinformatics tools. The designed sequence may include modifications, such as codon optimization, to enhance gene expression in specific organisms. Once the gene sequence is finalized, it is divided into shorter fragments, typically around 100-200 base pairs in length, for synthesis.

Gain deeper insights on the market and receive your free copy with TOC now @: Gene Synthesis Market Report

Gene synthesis can be achieved through various methods, including solid-phase DNA synthesis and enzymatic assembly. Solid-phase DNA synthesis involves adding nucleotides one-by-one to a growing DNA strand attached to a solid support. Enzymatic assembly methods utilize enzymes, such as DNA polymerases and ligases, to join the shorter DNA fragments together to form the complete gene sequence. After synthesis, the gene sequence can be inserted into a vector, which is a DNA molecule that can be propagated in host cells, for further cloning and manipulation. Gene synthesis has wide-ranging applications, including genetic engineering, synthetic biology, protein production, vaccine development, and gene therapy.

The advancements in gene synthesis technologies have made it more accessible and affordable, allowing researchers to create custom-designed genes for their specific research needs. Gene synthesis has also contributed to the rapid progress in fields such as synthetic biology, where complex gene circuits and novel biological systems can be constructed to perform specific functions. Overall, gene synthesis has revolutionized genetic research and biotechnology by providing a means to engineer and manipulate DNA sequences with precision and versatility.

Gene synthesis companies have been scaling up their operations to meet the growing demand for synthetic DNA. This includes the establishment of larger synthesis facilities and the utilization of high-throughput platforms, allowing for the parallel synthesis of multiple genes or larger gene constructs. The cost of gene synthesis has been decreasing over the years, making it more accessible to a wider range of researchers and industries. Advances in synthesis methods, automation, and economies of scale have contributed to cost reductions, enabling more affordable gene synthesis services. Codon optimization, the process of modifying gene sequences to optimize expression in specific host organisms, has become more sophisticated. Gene synthesis providers offer improved algorithms and tools for codon optimization, enabling the design of genes with enhanced expression levels and improved protein production. Additionally, the integration of gene editing technologies, such as CRISPR-Cas9, into gene synthesis workflows has opened up new possibilities for precise genetic modifications and genome engineering.

Many gene synthesis companies have developed user-friendly online platforms that allow researchers to easily submit gene synthesis orders and customize their desired gene sequences. These platforms often provide real-time pricing, design tools, and support for various modifications, including site-directed mutagenesis, fusion proteins, and reporter tags. Quality control measures in gene synthesis have improved, ensuring the accuracy and integrity of synthesized gene sequences. Companies employ rigorous verification processes, including DNA sequencing, to confirm the fidelity of synthesized genes. Some providers also offer additional quality control options, such as mass spectrometry-based analysis and functional testing. The application areas for gene synthesis continue to expand. Besides traditional research applications, gene synthesis is increasingly utilized in industrial biotechnology, pharmaceutical development, agricultural biotechnology, and gene therapy. The ability to engineer custom DNA sequences has facilitated the development of new bio-based products, therapeutic modalities, and improved crop traits.

[latestmarketresearchnews]

DNA Synthesis Market 2030: Brief Analysis of Top Countries Data, Growth and Drivers

The global DNA synthesis market was valued at USD 3.13 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.30% from 2024 to 2030. This growth can largely be attributed to the increasing demand for DNA synthesis driven by its applications in several fields, including molecular biology, genetic engineering, and clinical diagnostics and therapeutics. Additionally, the rising need for research in drug discovery and personalized medicine is expected to further boost market expansion during the forecast period.

The market is also seeing moderate merger and acquisition activity, driven by factors such as the desire to enhance competitive positioning within the industry and the need for consolidation in a rapidly growing market. Companies are increasingly entering into collaborations to support advancements in research and development (R&D) in diagnostics and therapeutics. For example, in April 2023, Twist Bioscience, a leader in the DNA synthesis market, announced a collaboration with Astellas Pharma to assist in antibody discovery for immunotherapies. These strategic alliances are expected to strengthen the market's growth trajectory as they enhance innovation in gene-related research.

Gather more insights about the market drivers, restrains and growth of the DNA Synthesis Market

Regional Insights:

North America DNA Synthesis Market Trends

North America held the largest market share, accounting for 39.76% of the global revenue in 2023. The region’s growth is driven by heightened public awareness about genetic disorders, along with robust medical facilities and substantial investments in research and development. The prevalence of chronic illnesses, such as cancer, diabetes, and cardiovascular diseases, further amplifies the demand for DNA synthesis as a tool for understanding and treating these conditions. Additionally, North American market players are heavily investing in gene synthesis and gene therapy research, creating a fertile environment for growth. The presence of leading DNA synthesis companies in the region, along with continuous advancements in gene editing technologies, further supports regional expansion.

U.S.

The U.S. DNA synthesis market has been experiencing significant growth, largely driven by the increasing demand for synthetic DNA and RNA sequences for various applications. These include molecular research, diagnostics, and therapeutics. The market's competitive landscape is diverse, consisting of both established players and emerging companies that are eager to secure a share of this expanding market. The U.S. market is particularly influenced by advancements in personalized medicine and genetic therapies, which heavily rely on DNA synthesis for drug development, disease prevention, and treatment personalization.

Asia Pacific DNA Synthesis Market Trends

The DNA synthesis market in the Asia Pacific region is anticipated to grow at the fastest rate, with a CAGR of 17.50% from 2024 to 2030. This growth is attributed to the increasing demand for synthetic DNA in research, diagnostics, and therapeutics, along with the rising prevalence of genetic diseases and the growing need for personalized medicine.

China

China is expected to experience the highest growth rate in the DNA synthesis market, with a projected CAGR of 21.41%. Factors contributing to this growth include the rising number of contract research organizations (CROs) and the outsourcing of drug discovery and development activities by pharmaceutical and biotech companies. Additionally, China’s focus on expanding and upgrading its gene synthesis facilities is further accelerating market growth. For example, in May 2023, GenScript expanded its oligonucleotide manufacturing facility in Jiangsu, China, to enhance its production capacity.

Japan

Japan is also expected to witness significant growth due to its aging population and emphasis on personalized medicine. As a leader in scientific research, especially in biotechnology and biopharmaceuticals, Japan has a strong focus on genetic studies and gene expression profiling, which are crucial to the DNA synthesis market. These factors are expected to further drive the demand for DNA synthesis in the region.

India

The DNA synthesis market in India is anticipated to grow rapidly due to the country’s high birth rate and the significant prevalence of genetic disorders, exacerbated by factors like consanguineous marriages and founder mutations. Government initiatives, such as the "Make in India" program and biotechnology R&D grants, are empowering domestic players and attracting foreign investments. Notably, the Department of Biotechnology (DBT) launched the UMMID initiative in 2019 to address inherited genetic diseases in newborns, further stimulating the DNA synthesis market.

Europe DNA Synthesis Market Trends

Europe represents another key region in the DNA synthesis market. This is largely due to strong government support, continuous advancements in research infrastructure, and an increasing prevalence of chronic diseases like cancer, cardiovascular conditions, and genetic disorders. The growing adoption of gene therapy is also contributing to the market's growth.

UK

The DNA synthesis market in the UK is poised for growth, driven by ongoing research and innovation in genetics and molecular studies. Government initiatives and strong healthcare infrastructure provide a conducive environment for biomedical research. For instance, in November 2023, the UK's approval of the CRISPR-based gene-editing therapy Casgevy marked a significant milestone, positioning the UK DNA synthesis market for further growth.

France

France faces a significant burden from cancer, which remains a leading cause of death in the country. The demand for DNA synthesis in France is driven by its growing role in cancer diagnostics and personalized medicine, particularly through gene expression profiling and liquid biopsies. Furthermore, cardiovascular diseases, such as atherosclerosis and heart failure, are contributing to the growing interest in oligonucleotides and genetic profiles for both diagnostic and therapeutic purposes, pushing the demand for DNA synthesis technologies.

Germany

Germany’s DNA synthesis market is expected to grow due to the country’s strong R&D focus in diagnostics and therapeutics. Germany is actively promoting biotechnology and healthcare infrastructure through initiatives like “Industrie 4.0” and providing grants for R&D. These efforts not only boost the domestic market but also attract foreign investment, further driving the DNA synthesis market in Germany.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global exosomes market size was estimated at USD 177.4 million in 2024 and is anticipated to grow at a CAGR of 28.73% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key DNA Synthesis Companies:

Thermo Fisher Scientific, Inc

Twist Bioscience

BIONEER CORPORATION

Eton Bioscience, Inc.

LGC Biosearch Technologies

IBA Lifesciences GmbH

Eurofins Scientific

Integrated DNA Technologies, Inc.

Quintara Biosciences

GenScript

Order a free sample PDF of the DNA Synthesis Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

DNA Synthesis Market Research Report 2030 By Players, Regions, Types & Applications

The global DNA synthesis market was valued at USD 3.13 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.30% from 2024 to 2030. This growth can largely be attributed to the increasing demand for DNA synthesis driven by its applications in several fields, including molecular biology, genetic engineering, and clinical diagnostics and therapeutics. Additionally, the rising need for research in drug discovery and personalized medicine is expected to further boost market expansion during the forecast period.

The market is also seeing moderate merger and acquisition activity, driven by factors such as the desire to enhance competitive positioning within the industry and the need for consolidation in a rapidly growing market. Companies are increasingly entering into collaborations to support advancements in research and development (R&D) in diagnostics and therapeutics. For example, in April 2023, Twist Bioscience, a leader in the DNA synthesis market, announced a collaboration with Astellas Pharma to assist in antibody discovery for immunotherapies. These strategic alliances are expected to strengthen the market's growth trajectory as they enhance innovation in gene-related research.

Gather more insights about the market drivers, restrains and growth of the DNA Synthesis Market

Regional Insights:

North America DNA Synthesis Market Trends

North America held the largest market share, accounting for 39.76% of the global revenue in 2023. The region’s growth is driven by heightened public awareness about genetic disorders, along with robust medical facilities and substantial investments in research and development. The prevalence of chronic illnesses, such as cancer, diabetes, and cardiovascular diseases, further amplifies the demand for DNA synthesis as a tool for understanding and treating these conditions. Additionally, North American market players are heavily investing in gene synthesis and gene therapy research, creating a fertile environment for growth. The presence of leading DNA synthesis companies in the region, along with continuous advancements in gene editing technologies, further supports regional expansion.

U.S.

The U.S. DNA synthesis market has been experiencing significant growth, largely driven by the increasing demand for synthetic DNA and RNA sequences for various applications. These include molecular research, diagnostics, and therapeutics. The market's competitive landscape is diverse, consisting of both established players and emerging companies that are eager to secure a share of this expanding market. The U.S. market is particularly influenced by advancements in personalized medicine and genetic therapies, which heavily rely on DNA synthesis for drug development, disease prevention, and treatment personalization.

Asia Pacific DNA Synthesis Market Trends

The DNA synthesis market in the Asia Pacific region is anticipated to grow at the fastest rate, with a CAGR of 17.50% from 2024 to 2030. This growth is attributed to the increasing demand for synthetic DNA in research, diagnostics, and therapeutics, along with the rising prevalence of genetic diseases and the growing need for personalized medicine.

China

China is expected to experience the highest growth rate in the DNA synthesis market, with a projected CAGR of 21.41%. Factors contributing to this growth include the rising number of contract research organizations (CROs) and the outsourcing of drug discovery and development activities by pharmaceutical and biotech companies. Additionally, China’s focus on expanding and upgrading its gene synthesis facilities is further accelerating market growth. For example, in May 2023, GenScript expanded its oligonucleotide manufacturing facility in Jiangsu, China, to enhance its production capacity.

Japan

Japan is also expected to witness significant growth due to its aging population and emphasis on personalized medicine. As a leader in scientific research, especially in biotechnology and biopharmaceuticals, Japan has a strong focus on genetic studies and gene expression profiling, which are crucial to the DNA synthesis market. These factors are expected to further drive the demand for DNA synthesis in the region.

India

The DNA synthesis market in India is anticipated to grow rapidly due to the country’s high birth rate and the significant prevalence of genetic disorders, exacerbated by factors like consanguineous marriages and founder mutations. Government initiatives, such as the "Make in India" program and biotechnology R&D grants, are empowering domestic players and attracting foreign investments. Notably, the Department of Biotechnology (DBT) launched the UMMID initiative in 2019 to address inherited genetic diseases in newborns, further stimulating the DNA synthesis market.

Europe DNA Synthesis Market Trends

Europe represents another key region in the DNA synthesis market. This is largely due to strong government support, continuous advancements in research infrastructure, and an increasing prevalence of chronic diseases like cancer, cardiovascular conditions, and genetic disorders. The growing adoption of gene therapy is also contributing to the market's growth.

UK

The DNA synthesis market in the UK is poised for growth, driven by ongoing research and innovation in genetics and molecular studies. Government initiatives and strong healthcare infrastructure provide a conducive environment for biomedical research. For instance, in November 2023, the UK's approval of the CRISPR-based gene-editing therapy Casgevy marked a significant milestone, positioning the UK DNA synthesis market for further growth.

France

France faces a significant burden from cancer, which remains a leading cause of death in the country. The demand for DNA synthesis in France is driven by its growing role in cancer diagnostics and personalized medicine, particularly through gene expression profiling and liquid biopsies. Furthermore, cardiovascular diseases, such as atherosclerosis and heart failure, are contributing to the growing interest in oligonucleotides and genetic profiles for both diagnostic and therapeutic purposes, pushing the demand for DNA synthesis technologies.

Germany

Germany’s DNA synthesis market is expected to grow due to the country’s strong R&D focus in diagnostics and therapeutics. Germany is actively promoting biotechnology and healthcare infrastructure through initiatives like “Industrie 4.0” and providing grants for R&D. These efforts not only boost the domestic market but also attract foreign investment, further driving the DNA synthesis market in Germany.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global exosomes market size was estimated at USD 177.4 million in 2024 and is anticipated to grow at a CAGR of 28.73% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key DNA Synthesis Companies:

Thermo Fisher Scientific, Inc

Twist Bioscience

BIONEER CORPORATION

Eton Bioscience, Inc.

LGC Biosearch Technologies

IBA Lifesciences GmbH

Eurofins Scientific

Integrated DNA Technologies, Inc.

Quintara Biosciences

GenScript

Order a free sample PDF of the DNA Synthesis Market Intelligence Study, published by Grand View Research.

[surbhijamdade]

Revenue Forecast and Competitive Landscape for the Oligonucleotide Synthesis Market

The Oligonucleotide Synthesis Market Report for 2024 provides a comprehensive overview of the Oligonucleotide Synthesis Market industry, presenting crucial data and insights into market dynamics, including growth drivers, challenges, and future potential. The report evaluates the Oligonucleotide Synthesis Market Components, focusing on significant opportunities and trends that could shape the industry's trajectory.

According to Straits Research, the global Oligonucleotide Synthesis Market market size was valued at USD 7.74 billion in 2023. It is projected to reach from USD 8.84 billion in 2024 to USD 25.57 billion by 2032, growing at a CAGR of 14.2% during the forecast period (2024–2032).

Get a Sample PDF/Excel of report starting from USD 995 :https://straitsresearch.com/report/oligonucleotide-synthesis-market/request-sample

Top Key Players of Oligonucleotide Synthesis Market :

Agilent Technologies, Inc.

ATDBio Ltd.

TriLink BioTechnologies LLC

Thermo Fisher Scientific

Nitto Denko Corporation

Merck KGaA

LGC Biosearch Technologies

Integrated DNA Technologies, Inc.

GenScript

GE Healthcare

Eurogentec

Eurofins

and more....

Key Insights from the Oligonucleotide Synthesis Market Report

Market Size Overview: The report provides comprehensive estimates of the Oligonucleotide Synthesis Marketsize, including value and sales volume, for the period.

Market Trends and Dynamics: An analysis of the key drivers, opportunities, challenges, and risks shaping the Oligonucleotide Synthesis Market.

Global Economic and Regional Impact: Evaluation of the effects of global inflation and the Russia-Ukraine conflict on the Oligonucleotide Synthesis Market.

Trade Flow Analysis: Detailed examination of import and export volumes of Oligonucleotide Synthesis Marketacross major regions.

Industry Value Chain: Insight into the Oligonucleotide Synthesis Marketvalue chain, covering raw materials, suppliers, manufacturing processes, distributors, and downstream customers.

Industry News, Policies, and Regulations: Coverage of the latest developments, policies, and regulations impacting the Oligonucleotide Synthesis Market.

Regional Analysis for Oligonucleotide Synthesis Market:

The regional analysis section of the report offers a thorough examination of the global Oligonucleotide Synthesis Market market, detailing the sales growth of various regional and country-level markets. It includes precise volume analysis by country and market size analysis by region for both past and future periods. The report provides an in-depth evaluation of the growth trends and other factors impacting the Oligonucleotide Synthesis Market market in key countries, such as the United States, Canada, Mexico, Germany, France, the United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil, and Saudi Arabia. Moreover, it explores the progress of significant regional markets, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Oligonucleotide Synthesis Market Segmentations:

By Product Type

Synthesized Oligonucleotide Product

Reagents

Equipment

By Applications

Research

PCR

Sequencing

Gene Synthesis

Diagnostics

Therapeutics

RNAi

Nucleic Acid Aptamers

Others

By End-User

Academic Research Institutes

Pharmaceutical and Biotechnology Companies

Diagnostic Laboratories

Others

Get Detail Market Segmentation :https://straitsresearch.com/report/oligonucleotide-synthesis-market/segmentation

Unit Economics must be known by C-suite professionals:

Cost of Goods Sold (COGS): Includes material, labor, and overhead costs in manufacturing.

R&D Costs: Investment in innovation and compliance with regulations.

Engineering and Design Costs: Resources for design, prototyping, and meeting technical standards.

Production Costs: Specialized manufacturing and quality control expenses.

Supply Chain Costs: Managing procurement and logistics for specialized components.

Testing and Quality Assurance: Costs for ensuring product safety and reliability.

SG&A Costs: Marketing, sales, and administrative expenses.

Revenue per Unit: Income from contracts, services, and licensing.

Gross Margin: Revenue minus COGS, showing unit profitability.

Break-even Analysis: Units or contracts needed to cover total costs.

Customer Acquisition Cost (CAC): Costs to secure new contracts.

Lifetime Value (LTV): Total revenue from a customer over time.

Capital Expenditure (CapEx): Investments in facilities and technology.

Economies of Scale: Cost reductions in larger production runs.

Profit Margin: Final profit after all expenses.

Top Reasons to Choose This Report

Access to Comprehensive Insights: Gain access to extensive analysis, research, and data that are often challenging to gather independently. This report provides valuable information, saving you significant time and effort.

Support for Informed Decisions: Enhance your decision-making process with in-depth insights into market trends, consumer behavior, and key industry factors. This report is essential for strategic planning, including investments, product development, and marketing strategies.

Gain a Competitive Edge: Stay competitive by understanding market dynamics and competitor strategies. The report provides detailed insights into competitor performance and market trends, helping you craft effective business strategies.

Cost-Effective Research Solution: Save on research costs by investing in this report, which offers a detailed and comprehensive analysis of the market. This cost-effective option eliminates the need for extensive independent research.

COVID-19 Aftermath and Geopolitical Influences: Russia-Ukraine Conflict and Middle East Crisis

The report explores the multifaceted impact of COVID-19 on the Oligonucleotide Synthesis Market market, covering both direct and indirect effects across global and local levels. It discusses market size, trends, and growth trajectories in the Oligonucleotide Synthesis Market , classified by type, application, and customer sector. Additionally, it provides a detailed evaluation of market development components before and after the pandemic, supported by a PESTEL analysis to assess key influencers and barriers to market entry. We offer the flexibility to customize the report based on specific regions, applications, or any other statistical details. Our goal is to align our analysis with your specific needs, ensuring a more complete market study. The final report will also examine the impact of the Russia-Ukraine War on the Oligonucleotide Synthesis Market market, assessing how these geopolitical events are influencing current market conditions and future opportunities.

This Report is available for purchase on :https://straitsresearch.com/buy-now/oligonucleotide-synthesis-market

About Us:

Straits Research is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & research reports.

Contact Us: email: sales@straitsresearch.com Address: 825 3rd Avenue, New York, NY, USA, 10022 Tel: +1 646 905 0080 (U.S.) +91 8087085354 (India) +44 203 695 0070 (U.K.)

[insightfulblogz]

Oligonucleotide Synthesis Market Future Growth, Scope, Price, and Forecast 2032

Oligonucleotide synthesis has emerged as a crucial component in modern biotechnology, enabling precise manipulation of genetic material for applications ranging from medical diagnostics to therapeutics. These short DNA or RNA molecules, commonly synthesized in laboratories, are instrumental in gene editing, polymerase chain reactions (PCR), molecular cloning, and various other research methods. With advances in synthetic biology, oligonucleotides have become fundamental tools for developing targeted therapies, especially for genetic disorders and cancer treatments. The field has seen remarkable growth as researchers and clinicians leverage these synthesized sequences to enhance accuracy and efficiency in gene-targeting techniques.

The synthesis of oligonucleotides requires highly specialized equipment and meticulous methodologies to ensure the precision of each nucleotide sequence. Leading techniques, such as solid-phase synthesis, phosphoramidite chemistry, and enzymatic synthesis, have contributed to achieving high-fidelity results, ensuring the effectiveness of synthesized oligonucleotides in clinical and research applications. As demand continues to grow for gene-based therapies, diagnostics, and advanced research applications, the market for oligonucleotide synthesis is projected to witness significant expansion in the coming years.

The Oligonucleotide Synthesis Market size was estimated at USD 3.67 billion in 2023 and is expected to reach USD 11.21 billion by 2032 at a CAGR of 13.22% during the forecast period of 2024-2032.

Future Growth

The future growth of the oligonucleotide synthesis market is anticipated to be driven by the increasing interest in gene-based therapies and personalized medicine. Advances in genomic research are revealing new pathways and genetic markers that can be targeted with precision therapies, propelling the demand for custom-synthesized oligonucleotides. Additionally, expanding applications in gene silencing, antisense oligonucleotides, and CRISPR technology are catalyzing a rise in demand for oligonucleotide synthesis as a tool for genetic intervention and cellular engineering.

Global investments in biotechnology research and development are further strengthening the market outlook. Governments and private institutions are increasingly funding initiatives aimed at discovering new genetic therapies and diagnostic tools, fueling the demand for oligonucleotide synthesis services. The field is also expected to benefit from innovations in synthesis processes, such as automation and miniaturization, which improve efficiency, reduce costs, and enable high-throughput applications in large-scale research studies and clinical applications.

Drivers

The rising prevalence of genetic disorders and chronic diseases is a major driver of the oligonucleotide synthesis market. As gene therapy and molecular diagnostics gain traction in healthcare, oligonucleotide synthesis has become an essential process in developing effective treatments and accurate diagnostic tests. Additionally, the ongoing evolution of biotechnology, characterized by advancements in genome editing tools such as CRISPR-Cas9, continues to drive demand for oligonucleotide synthesis. Researchers rely on synthesized oligonucleotides to design CRISPR guides, primers, and probes, highlighting their value in groundbreaking genetic interventions.

Another significant driver is the growth in pharmaceutical and biotechnological research aimed at creating personalized treatments tailored to an individual’s genetic makeup. As precision medicine gains momentum, the role of synthesized oligonucleotides becomes increasingly central in designing therapies that specifically target the genetic origins of diseases. The demand for high-throughput synthesis is also bolstered by academic and research institutions focusing on genomics, proteomics, and metabolomics, further stimulating the market’s expansion.

Key Takeaways

The oligonucleotide synthesis market is crucial to advancements in biotechnology, particularly in gene-based therapies and molecular diagnostics.

Future growth is expected to be driven by the rise in personalized medicine, genomic research, and innovative genome editing tools.

Major companies such as Integrated DNA Technologies and Thermo Fisher Scientific are pivotal players, investing in advanced synthesis techniques.

The demand is propelled by the rising incidence of genetic disorders and the need for precision medicine solutions.

Technological advancements in synthesis processes, including automation and miniaturization, are set to optimize production efficiency and accuracy.

Get a Free Sample Copy of the Report: https://www.snsinsider.com/sample-request/3722 

Conclusion

In conclusion, oligonucleotide synthesis stands at the forefront of biotechnology, empowering researchers, clinicians, and pharmaceutical developers to innovate with precision and specificity. The market is poised for substantial growth, fueled by expanding applications in gene-based research and treatment approaches. As the demand for personalized medicine and targeted therapies rises, synthesized oligonucleotides are expected to play an increasingly important role in diagnosing and treating complex genetic diseases. With continued investment in technological advancements, the future of oligonucleotide synthesis holds promising potential for furthering scientific understanding and improving patient outcomes in healthcare.

[healthcaremarketanalysis]

mRNA Synthesis & Manufacturing Market worth $738.3 million by 2029

The mRNA synthesis and manufacturing market is projected to reach USD 738.3 million in 2029 from USD 624.4 million in 2024. This market is projected to grow at a CAGR of 3.4% over the forecast period. The primary drivers behind the expansion of this industry are the Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mRNA technology, advancements in mRNA synthesis technology, increased outsourcing for mRNA synthesis and modification, and collaborations among industry players. However, stability, storage, and manufacturing scalability present a challenge to this industry. This is further amplified by the slow patient adoption rate and the complexity of the development of mRNA-based therapy.

In many important respects, artificial intelligence (AI) is transforming the mRNA synthesis and manufacturing sector. First, by scanning large databases to find suitable mRNA sequences for therapeutic usage, artificial intelligence speeds up drug research and development greatly. Developed tools like the LinearDesign AI aim to maximize mRNA sequences, therefore producing vaccines with more antibody responses than conventional techniques. From raw material acquisition to final product packaging, artificial intelligence maximizes several manufacturing steps, thereby lowering costs and raising efficiency. AI-powered predictive maintenance reduces downtime and guarantees manufacturing equipment’s seamless running.

Download PDF Brochure:

Browse in-depth TOC on “mRNA Synthesis & Manufacturing Market”

250 — Tables

50 — Figures

250 — Pages

The market is expanding rapidly due to factors such as the development of mRNA-based vaccines and expanded applications such as cancer immunotherapies. Furthermore, improvements in mRNA synthesis technology, a rise in mRNA synthesis and modification outsourcing, and industry players working together to create mRNA therapies all contribute to the growth of the mRNA synthesis and manufacturing market. Additionally, factors such as advancements in drug delivery technologies, growth in the regenerative medicines market, and increasing government funding and private investments in the mRNA therapeutics market will further provide revenue growth opportunities for the players operating in mRNA synthesis & manufacturing.

Based on product type, the mRNA synthesis and manufacturing products market is divided into two broad categories, consumables and instruments. The consumables segment of the market held the largest market share in 2023, due to the sustained use of consumables such as nucleotides, RNA polymerase, reverse transcriptase, buffer, and reagents that also require frequent repurchases. The consumables segment will be experiencing high growth due to several factors, including an increase in the mRNA therapeutics pipeline and growing investments made to develop mRNA-based therapeutics, advancement in mRNA synthesis technologies, increase in demand for consumables among contract service providers with the growing trend of outsourcing.

Based on service type, the global mRNA synthesis and manufacturing services market has been categorized into four service types: mRNA synthesis, modification, and related activities; purification of mRNA; analytical and characterization services; and scale-up and manufacture activities. In 2023, the mRNA synthesis and modification services captured the highest market share because of the demand for custom and modified mRNA sequences, which are intended to enhance therapeutic candidates for the molecules market. Given the expanding uses of the mRNA technology, researchers and developers are looking for mRNA sequences that can incorporate protein expression enhancement or immune response improvement.

Based on application, the market for mRNA synthesis and manufacturing has been divided into segments including vaccines and cell & gene therapy. The vaccine segment has the dominant share in the market in 2023. The large share of this segment can be supported by the large number of clinical trials of mRNA vaccines for various diseases infectious diseases, cancer and rare genetic disorders. The remarkable success of mRNA-based COVID-19 vaccines has not only proven the efficacy & scalability of mRNA technology but also catalysed interest in targeting other therapy areas, such as cancer and rare diseases.

Based on end user, the mRNA synthesis and manufacturing market has been categorized into pharmaceutical and biotechnology companies, academic and research institutes, and CROs and CDMOs. In 2023, pharmaceutical and biotechnology companies dominated the market for mRNA synthesis and manufacturing. According to the market’s emerging needs, companies are investing to develop next-generation biologics such as mRNA therapeutics. Higher research and development activities of companies to develop mRNA therapeutics and cell and gene therapies have resulted in rising needs for specialized consumables and instruments as well as synthesis, modification, purification, analysis, and characterization services.

Request Sample Pages:

The global mRNA synthesis and manufacturing market is consolidated with the top five players — Thermo Fisher Scientific Inc. (US), Aldevron, LLC. (Danaher Corporation) (US), TriLink BioTechnologies (US), GenScript (US), and Merck KGaA (Germany). Other prominent market players include, New England Biolabs (US), Promega Corporation (US), Sartorius AG (Germany), WuXi Biologics (China), Takara Bio Inc. (Japan), GENEWIZ (Azenta US, Inc.) (US), Lonza (Switzerland), Telesis Bio Inc. (US), Aurigene Pharmaceutical Services Ltd. (Dr. Reddy’s Laboratories Ltd.) (India), ST Pharm (South Korea), AGC Biologics (US).

Thermo Fisher Scientific Inc. (US):

Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, is a leading player in mRNA synthesis and manufacturing, offering a broad range of products and services tailored to this field. The company provides advanced solutions for mRNA synthesis, including custom RNA synthesis services and reagents through its GeneArt platform, which supports the development of mRNA constructs for research, therapeutic, and vaccine applications. Thermo Fisher’s technologies enable efficient in vitro transcription (IVT) and include automated solutions that enhance scalability and production efficiency. Their extensive expertise, quality assurance measures, and global reach position them as a key player in advancing mRNA technology and supporting the development of next-generation therapeutics and vaccines.

Aldevron, LLC. (Danaher Corporation) (US):

Aldevron, established in 1998 and based in Fargo, North Dakota, is a key player in the nucleic acid synthesis industry, particularly known for its expertise in mRNA synthesis and manufacturing. The company is highly regarded for producing high-quality mRNA and plasmid DNA, essential for cutting-edge applications in vaccine development, gene therapy, and other biotechnological innovations. Aldevron’s offerings include custom RNA synthesis and cGMP-compliant mRNA production, ensuring that their products meet the stringent standards required for clinical use. Aldevron’s robust quality control and assurance processes further guarantee the reliability and efficacy of their products. As a global leader in the field, Aldevron has expanded its facilities and technological infrastructure to meet growing demand, establishing a significant presence in the biopharmaceutical sector. Their collaborations with biotechnology firms, pharmaceutical companies, and research institutions underscore their pivotal role in advancing mRNA technology and supporting the development of next-generation therapies and vaccines.

TriLink BioTechnologies (US):

TriLink BioTechnologies, a subsidiary of Maravai LifeSciences based in San Diego, California, is a key player in mRNA synthesis and manufacturing. The company excels in providing high-quality nucleic acid products and services, with a strong focus on mRNA technology. TriLink offers comprehensive mRNA synthesis services, including the production of custom mRNA and chemically modified mRNA, which enhances stability and translation efficiency — crucial for effective therapeutic and vaccine development. Utilizing advanced in vitro transcription technologies, TriLink ensures high yield and purity in their mRNA products.

For more information, Inquire Now!

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies — helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1–888–600–6441

UK +44–800–368–9399

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

[tushar38]

Video Telematics Market: Key Players, Applications, and Technological Advancements

 Introduction to DNA and Gene Cloning Services Market

The DNA and Gene Cloning Services Market is experiencing robust growth, driven by the increasing demand for gene editing technologies, advancements in molecular biology, and rising applications in biotechnology and healthcare. These services support research in drug development, agriculture, and personalized medicine, allowing scientists to clone, manipulate, and study genes. The market benefits from innovations in CRISPR, next-gen sequencing, and synthetic biology. With the expansion of biopharma and growing investments in genetic research, the DNA and gene cloning services sector is poised for significant growth in the coming years.

The DNA and Gene Cloning Services Market is Valued USD 3.02 billion in 2024 and projected to reach USD 7.84 billion by 2030, growing at a CAGR of CAGR of 14.6% During the Forecast period of 2024-2032.Its applications span drug development, gene therapy, agriculture, and synthetic biology. With advances in gene editing tools such as CRISPR and the increasing demand for personalized medicine, the market is expanding rapidly. Companies offer customized cloning services, including vector construction, mutagenesis, and gene synthesis, driving market competition and fostering innovation.

Access Full Report :https://www.marketdigits.com/checkout/3785?lic=s

Major Classifications are as follows:

By Product Type

Custom Cloning

Gene Synthesis

Sub-cloning

Others

By Application

DNA Sequencing

Genotyping

Mutagenesis

Others

By End-user

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Others

Key Region/Countries are Classified as Follows:

◘ North America (United States, Canada,) ◘ Latin America (Brazil, Mexico, Argentina,) ◘ Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) ◘ Europe (UK,Germany,France,Italy,Spain,Russia,) ◘ The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South

Key Players of DNA and Gene Cloning Services Market

Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Twist Bioscience and Others

Market Drivers in DNA and Gene Cloning Services Market

Technological Advancements: Cutting-edge tools like CRISPR, along with next-generation sequencing, have revolutionized the field, driving the demand for cloning services.

Growth in Biotechnology and Pharmaceuticals: The increasing use of gene cloning in drug discovery, gene therapy, and personalized medicine boosts market growth.

Rising R&D Investments: Governments and private sector investments in genetic research contribute to expanding the market.

Market Challenges in DNA and Gene Cloning Services Market

Regulatory Hurdles: Stricter government regulations around gene manipulation and cloning practices present challenges for service providers.

Ethical Concerns: Ethical debates surrounding cloning, particularly human gene cloning, can restrict market expansion in certain regions.

High Costs: The technologies and expertise required for cloning services remain expensive, limiting access for smaller research institutions.

Market Opportunities of DNA and Gene Cloning Services Market

Expansion in Precision Medicine: The growing demand for tailored treatments provides immense opportunities for gene cloning in personalized medicine.

Agricultural Advancements: Applications in genetically modified crops for improved yield and resistance create new markets for cloning services.

Emerging Markets: Expanding biotechnology sectors in Asia-Pacific and Latin America offer significant growth potential.

Conclusion

The DNA and Gene Cloning Services Market is poised for significant expansion, driven by technological advancements, increasing research activities, and growing demand for precision medicine. While challenges such as regulatory issues and high costs exist, the market’s vast opportunities in sectors like agriculture, personalized medicine, and biopharma ensure a promising future. Investments in innovation and strategic partnerships will be key in harnessing the full potential of this evolving market.

[health-views-updates]

gRNA Market 2024 Share, Trend and Segmentation Forecast 2032

The gRNA Market Revenue is witnessing robust growth due to significant advancements in gene editing technologies and increased investment in precision medicine. According to a recent report by SNS Insider, the global gRNA market is anticipated to expand significantly over the coming years as the demand for CRISPR-based gene editing solutions continues to rise. The growing focus on personalized medicine, research into genetic diseases, and agricultural biotechnology applications are all contributing to the gRNA market's momentum.

A major factor driving this growth is the increased focus on gene editing tools like CRISPR, which require guide RNA (gRNA) to direct the CRISPR-Cas9 complex to the correct genetic sequence. This application has paved the way for groundbreaking research and innovation in genome editing, including genetic disease treatment, therapeutic development, and crop engineering. Moreover, advancements in synthetic biology and biotechnology are expected to fuel market growth as companies invest heavily in R&D for gene editing applications across multiple sectors.

In addition, the rise of government funding, academic research, and private investment in the genomics industry is driving the demand for guide RNA products. With applications ranging from therapeutics to diagnostics, the gRNA market is rapidly expanding its footprint in the global biotechnology and healthcare sectors.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/4484

Technological Innovations and Strategic Collaborations Bolster Market Expansion

Innovations in CRISPR-Cas technology have enabled more precise and efficient gene editing, enhancing the accuracy and effectiveness of gRNA products. Emerging methods, such as high-throughput synthesis and automation in gRNA production, are allowing companies to produce high-quality, cost-effective gRNA sequences at scale. Furthermore, strategic collaborations between biotech firms, research institutions, and universities are accelerating advancements in the field and driving the demand for specialized gRNA products.

As the healthcare industry prioritizes precision medicine, the demand for high-performance gene editing tools has grown exponentially. The versatility of CRISPR-based technologies, including their potential to address genetic disorders and cancer, has brought gRNA products to the forefront of medical research and development. Moreover, the increasing interest in agricultural biotechnology, where gRNA is used for crop enhancement and pest resistance, is contributing to the market’s growth trajectory.

Asia-Pacific Leads Growth Due to Increased Investments in Biotech and Genomics

The Asia-Pacific region is emerging as a significant player in the gRNA market, driven by investments in biotechnology and growing interest in genomics research. Countries like China and India are increasing their focus on developing gene editing tools and building a solid infrastructure for biotechnological advancements. With government initiatives supporting genetic research, the region is anticipated to witness a surge in demand for gRNA products over the forecast period.

Challenges and Future Outlook

Despite the growth opportunities, the gRNA market faces challenges related to ethical concerns, regulatory scrutiny, and technical limitations in CRISPR technology. However, companies are actively working on developing new techniques and addressing these issues to facilitate the responsible use of gene editing. As technological improvements continue and regulatory frameworks evolve, the global gRNA market is expected to see sustained growth and adoption across various industries.

With applications extending beyond healthcare to agriculture and industrial biotechnology, the gRNA market presents enormous potential for future innovations and societal impact.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[tamanna31]

New Trends of Oligonucleotide Synthesis Market with Industry Analysis by 2024 – 2030

Oligonucleotide Synthesis Industry Overview

The global oligonucleotide synthesis market size was estimated at USD 3.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. 

The decreasing prices of sequencing have led to increasing demand for custom-made nucleotides for applications across genetic testing, research, forensics applications, and drug development. This has further boosted the demand for oligonucleotide synthesis. The COVID-19 pandemic has affected every market globally and there has been a surge in the demand for efficient treatment against COVID-19.

Gather more insights about the market drivers, restrains and growth of the Oligonucleotide Synthesis Market

Oligonucleotide therapeutics hold immense potential for treating chronic conditions such as cardiovascular diseases, cancers, and retinal disorders. Emerging new applications of oligo sequences in multiple fields of biotechnology are expected to increase market growth. Demand for molecular diagnostics in precision care is an important emerging application field for oligonucleotide synthesis.

The introduction of advanced techniques such as CRISPR and high-throughput sequencing for gene expression analysis has simplified the genetic screening and modification of genomes. Such innovations are observed to influence the demand for oligonucleotide synthesis. Manufacturers invest in technology development to enable the production of long Oligonucleotides with higher precision and better yield to cater to the growing need for custom oligos.

The availability of a regulatory environment that supports the progress of genomics is the key factor contributing to the market growth. Changes in the regulatory policies to provide a well-framed environment for advanced biological research and application in human use are expected to influence demand for oligonucleotide synthesis significantly. Stem cells, regenerative medicine, genetic engineering, and synthetic biology are the prominent fields identified with high potential in healthcare. For instance, the International Society for Stem Cell Research (ISSCR) ethics and public policy committee aims to recognize and resolve issues by conducting open discussions. The committee includes experts in ethics, law, and social policy worldwide.

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Some of the key players operating in the market include Merck KGaA, Thermo Fisher Scientific, Inc., and Agilent Technologies. These players focus on business strategies such as partnerships/collaborations, product launches, and expansion. Twist Bioscience, Biolegio, and LGC Biosearch Technologies are some of the emerging market participants in the oligonucleotide market. These players primarily focus on expansion and partnerships to strengthen their position in the market.

Key Oligonucleotide Synthesis Companies:

·         Thermo Fisher Scientific, Inc.

·         Merck KGaA

·         Danaher Corporation

·         Dharmacon Inc.

·         Agilent Technologies

·         Bio-synthesis

·         Kaneka Eurogentec S.A

·         LGC Biosearch Technologies

·         Biolegio

·         Twist Bioscience

Recent Developments

In October 2023, IDT inaugurated a new therapeutic manufacturing facility to meet the increasing demand in genomic medicine. The new facility is equipped to support the production of therapeutic oligonucleotides, catering to the expanding needs in the field of genomics and personalized medicine.

In September 2023, Danaher Corporation (Integrated DNA Technologies) introduced a range of xGen NGS products tailored for the Ultima Genomics UG 100TM platform. The suite includes adapters, primers, and universal blockers, catering to various applications such as DNA, RNA, & methylation sequencing workflows. This offering is complemented by IDT's proven hybridization capture chemistry, enhancing versatility for researchers.

In July 2023, Analytix introduced two new instruments designed for organic synthesis, including wavePREP, tailored for oligonucleotide synthesis, and Xelsius, a workstation for multireaction synthesis.

In May 2023, GenScript expanded its life sciences facility in Zhenjiang, Jiangsu, China, to offer a rapid, high-purity oligonucleotide and peptide synthesis service tailored for research & development as well as preclinical applications.

In May 2023, Twist Bioscience and CeGaT GmbH launched the Twist Alliance CeGaT RNA Fusion Panel. This collaborative effort aims to provide a specialized tool for oncology research, facilitating the detection of RNA fusions and enabling transcript variant analysis. RNA fusions, a result of chromosomal arrangements often seen in cancers, can now be efficiently studied using this newly introduced panel.

In February 2023, Fluor Corp. and Agilent Technologies, Inc. collaborated to enhance its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado. Under this collaboration, Fluor is expected to support the project's engineering and procurement. The total value of the project is evaluated at USD 725 million.

Order a free sample PDF of the Oligonucleotide Synthesis Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Oligonucleotide Synthesis Market Analysis And Segment Forecast 2024-2030

The global oligonucleotide synthesis market size was estimated at USD 3.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. 

The decreasing prices of sequencing have led to increasing demand for custom-made nucleotides for applications across genetic testing, research, forensics applications, and drug development. This has further boosted the demand for oligonucleotide synthesis. The COVID-19 pandemic has affected every market globally and there has been a surge in the demand for efficient treatment against COVID-19.

Gather more insights about the market drivers, restrains and growth of the Oligonucleotide Synthesis Market

Oligonucleotide therapeutics hold immense potential for treating chronic conditions such as cardiovascular diseases, cancers, and retinal disorders. Emerging new applications of oligo sequences in multiple fields of biotechnology are expected to increase market growth. Demand for molecular diagnostics in precision care is an important emerging application field for oligonucleotide synthesis.

The introduction of advanced techniques such as CRISPR and high-throughput sequencing for gene expression analysis has simplified the genetic screening and modification of genomes. Such innovations are observed to influence the demand for oligonucleotide synthesis. Manufacturers invest in technology development to enable the production of long Oligonucleotides with higher precision and better yield to cater to the growing need for custom oligos.

The availability of a regulatory environment that supports the progress of genomics is the key factor contributing to the market growth. Changes in the regulatory policies to provide a well-framed environment for advanced biological research and application in human use are expected to influence demand for oligonucleotide synthesis significantly. Stem cells, regenerative medicine, genetic engineering, and synthetic biology are the prominent fields identified with high potential in healthcare. For instance, the International Society for Stem Cell Research (ISSCR) ethics and public policy committee aims to recognize and resolve issues by conducting open discussions. The committee includes experts in ethics, law, and social policy worldwide.

Oligonucleotide Synthesis Market Segmentation

Grand View Research has segmented the global oligonucleotide synthesis market report based on product & service, application, and region:

Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

• Oligonucleotides

o DNA

o Column-based

o Array-based

o RNA

o By Technology

o Column-based

o Array-based

o By Type

o Short RNA Oligos (<65 nt)

o Long RNA Oligos (>65 nt)

o CRISPR (sgRNA)

• Equipment/Synthesizer

• Reagents

• Services

o DNA

o Custom Oligo Synthesis Services

o 25 nmol

o 50 nmol

o 200 nmol

o 1000 nmol

o 10000 nmol

o Modification Services

o Purification Services

o RNA

o Custom Oligo Synthesis Services

o 25 nmol

o 100 nmol

o 1000 nmol

o 10000 nmol

o Modification Services

o Purification Services

Application Outlook (Revenue, USD Million, 2018 - 2030)

• PCR Primers

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• PCR Assays & Panels

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• Sequencing

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• DNA Microarrays

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• Fluorescence In Situ Hybridization (FISH)

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• Antisense Oligonucleotides

o Academic Research Institutes

o Diagnostic Laboratories

o Pharmaceutical - Biotechnology Companies

• Other Applications

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Spain

o Italy

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o South Korea

o Australia

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

• The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Some of the key players operating in the market include Merck KGaA, Thermo Fisher Scientific, Inc., and Agilent Technologies. These players focus on business strategies such as partnerships/collaborations, product launches, and expansion. Twist Bioscience, Biolegio, and LGC Biosearch Technologies are some of the emerging market participants in the oligonucleotide market. These players primarily focus on expansion and partnerships to strengthen their position in the market.

Key Oligonucleotide Synthesis Companies:

• Thermo Fisher Scientific, Inc.

• Merck KGaA

• Danaher Corporation

• Dharmacon Inc.

• Agilent Technologies

• Bio-synthesis

• Kaneka Eurogentec S.A

• LGC Biosearch Technologies

• Biolegio

• Twist Bioscience

Recent Developments

• In October 2023, IDT inaugurated a new therapeutic manufacturing facility to meet the increasing demand in genomic medicine. The new facility is equipped to support the production of therapeutic oligonucleotides, catering to the expanding needs in the field of genomics and personalized medicine.

• In September 2023, Danaher Corporation (Integrated DNA Technologies) introduced a range of xGen NGS products tailored for the Ultima Genomics UG 100TM platform. The suite includes adapters, primers, and universal blockers, catering to various applications such as DNA, RNA, & methylation sequencing workflows. This offering is complemented by IDT's proven hybridization capture chemistry, enhancing versatility for researchers.

• In July 2023, Analytix introduced two new instruments designed for organic synthesis, including wavePREP, tailored for oligonucleotide synthesis, and Xelsius, a workstation for multireaction synthesis.

• In May 2023, GenScript expanded its life sciences facility in Zhenjiang, Jiangsu, China, to offer a rapid, high-purity oligonucleotide and peptide synthesis service tailored for research & development as well as preclinical applications.

• In May 2023, Twist Bioscience and CeGaT GmbH launched the Twist Alliance CeGaT RNA Fusion Panel. This collaborative effort aims to provide a specialized tool for oncology research, facilitating the detection of RNA fusions and enabling transcript variant analysis. RNA fusions, a result of chromosomal arrangements often seen in cancers, can now be efficiently studied using this newly introduced panel.

• In February 2023, Fluor Corp. and Agilent Technologies, Inc. collaborated to enhance its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado. Under this collaboration, Fluor is expected to support the project's engineering and procurement. The total value of the project is evaluated at USD 725 million.

Order a free sample PDF of the Oligonucleotide Synthesis Market Intelligence Study, published by Grand View Research.

[credenceresearchdotblog]

The Clinical Oncology Next Generation Sequencing Market is projected to grow from USD 624.66 million in 2024 to USD 2185.98 million by 2032, reflecting a compound annual growth rate (CAGR) of 16.95%.The Clinical Oncology Next-Generation Sequencing (NGS) market is rapidly transforming the landscape of cancer diagnostics and treatment. NGS, a powerful and versatile tool, enables the comprehensive analysis of genetic mutations associated with various types of cancer. By identifying these mutations, NGS helps in tailoring personalized treatments, leading to better patient outcomes. The market for NGS in clinical oncology is expanding due to advancements in technology, increasing demand for personalized medicine, and the growing prevalence of cancer worldwide.

Browse the full report at https://www.credenceresearch.com/report/clinical-oncology-next-generation-sequencing-market

Market Dynamics

The global Clinical Oncology NGS market is driven by several key factors. The rising incidence of cancer, coupled with the growing awareness of the benefits of early detection and personalized treatment, is a primary driver. According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, with an estimated 19.3 million new cases and 10 million cancer-related deaths in 2020. The increasing burden of cancer has necessitated the development of advanced diagnostic tools like NGS to improve early detection and treatment strategies.

Technological advancements in NGS platforms have significantly reduced the cost of sequencing, making it more accessible to healthcare providers and patients. The ability of NGS to sequence multiple genes simultaneously with high accuracy and sensitivity has revolutionized cancer genomics. This has led to the identification of actionable mutations that can be targeted with specific therapies, thereby enhancing the effectiveness of treatment and reducing adverse effects.

Another significant factor contributing to the growth of the Clinical Oncology NGS market is the increasing adoption of personalized medicine. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, and NGS plays a critical role in this approach. By analyzing a patient’s genetic makeup, NGS can identify specific mutations that drive cancer, enabling the selection of targeted therapies that are more likely to be effective.

Challenges and Opportunities

Despite the promising growth, the Clinical Oncology NGS market faces several challenges. One of the primary challenges is the complexity of data analysis and interpretation. NGS generates vast amounts of data, and interpreting this data requires sophisticated bioinformatics tools and expertise. Additionally, the lack of standardization in NGS protocols and the high cost of advanced sequencing platforms are significant barriers to widespread adoption.

However, these challenges also present opportunities for market players. The development of user-friendly bioinformatics tools and cloud-based platforms for data analysis can help overcome the challenges associated with data interpretation. Moreover, continued advancements in sequencing technology and cost reductions will likely drive further adoption of NGS in clinical oncology.

Key Player Analysis

Thermo Fisher Scientific Inc.

Oxford Nanopore Technologies Ltd.

Agilent Technologies, Inc.

PerkinElmer, Inc.

Pacific Biosciences of California, Inc.

Qiagen N.V.

Illumina Inc.

Bio-Rad Laboratories, Inc.

BGI Group

Hoffmann-La Roche Ltd.

Segments:

Based on Component:

Sequencing platforms

Sequencing products

Kits and reagents

Services

Based on Technology:

Ion semiconductor sequencing

Pyro-sequencing

Synthesis sequencing (SBS)

Real time sequencing (SMRT)

Ligation sequencing

Reversible dye termination sequencing

Nano-pore sequencing

Based on Application:

Whole tumor genome sequencing

Whole tumor exome sequencing

Targeted tumor genome profiling

Tumor transcriptome sequencing

Tumor-normal comparisons

Others

Based on End User:

Hospitals

Laboratories

Clinical research organizations

Diagnostic laboratories

Others

Based on the Geography:

North America

US

Canada

Mexico

Europe

Germany

Uk

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Australia

Rest of Asia Pacific

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

UAE

Saudi Arabia

Qatar

South Africa

Rest of the Middle East & Africa

Browse the full report at https://www.credenceresearch.com/report/clinical-oncology-next-generation-sequencing-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[poonamcmi]

Oligonucleotide Synthesis Market is Expected to Witness High Growth Owing to Rising Biotechnology Research and Development

The oligonucleotide synthesis market involves the production of shorter sequences of nucleic acids known as oligonucleotides that are widely used in research, diagnostics and therapeutics applications. Oligonucleotides play a vital role in gene expression studies, next-generation sequencing, DNA & RNA analysis, qPCR and molecular diagnostics. The increasing focus on biotechnology research especially in life sciences and genomics has boosted the demand for specialized oligonucleotides.

The Global oligonucleotide synthesis market is estimated to be valued at US$ 4565 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period of 2024 to 2031.

Key Takeaways Key players operating in the oligonucleotide synthesis are Forte Research Systems (India), ICON plc (Ireland), Merge healthcare incorporated (U.S.), Bio-Optronics (U.S.), DSG INC (U.S.), ArisGlobal (India), ERT Clinical Bioclinica (U.S.), Oracle Corporation (U.S.), Medidata Solutions (U.S.), DATATRAK International, Inc. (U.S.), and MedNet Solutions, Inc., (U.S.) among others. These key players are focusing on partnerships and new technology development to expand their oligonucleotide synthesis capabilities.

Key Oligonucleotide Synthesis Market Demand include increasing research in personalized medicine and precision genomics. Additionally, the growing pipeline of oligo-based drugs and clinical trials for rare diseases will provide momentum.

With regards to geographical expansion, North America dominates the global oligonucleotide synthesis market followed by Europe. However, Asia Pacific is expected to witness highest growth rate owing to increasing government support for biotech sector and growing industry investments in China and India.

Market Drivers Increasing R&D expenditure for biotechnology research especially in life sciences and biopharmaceutical industry is a key factor contributing to the Oligonucleotide Synthesis Market Size And Trends Oligonucleotides play a vital role in new drug discovery and development which is propelling many biotech companies to adopt oligo synthesis. Rising applications of oligos in development of advanced therapeutics like antisense oligonucleotides and siRNA is expected to drive the market during the forecast period.

PEST Analysis Political: Government regulations around drug research and development have an impact. Changes in healthcare policies and funding also affect the market. Economic: The state of the economy influences research spending by pharmaceutical companies and academic institutions, affecting demand. Rising healthcare costs drive need for new drug therapies. Social: An aging global population with increased prevalence of diseases like cancer is leading to higher demand for advanced drug development and diagnostic tools. Social attitudes around health and biotech also evolve over time.

Technological: Advancements in DNA sequencing, synthesis and analysis technologies enable new applications and drive down costs, expanding the potential market. Automation and artificial intelligence are enhancing R&D productivity.

North America holds the largest share in terms of value currently due to heavy spending on drug R&D by major players in the US and Canada. However, Asia Pacific is expected to grow at the fastest rate during the forecast period as the pharmaceutical industry expands rapidly in major emerging economies like China and India. These countries are making large investments in research and increasing regulatory approvals are also supporting market growth.

Europe accounts for a sizable share as well owing to extensive government funding for research programs. However, the high costs of oligonucleotide therapies has limited their use thus far. If pricing and reimbursement improve in the future, the European market could witness stronger growth. On the other hand, the Middle East and Africa region is relatively nascent but demand may rise over time with economic development across various nations. Get More Insights On, Oligonucleotide Synthesis Market About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, c

[onlinecareerestmarket]

T7 RNA Polymerase Market Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

The T7 RNA Polymerase market represents the nexus of scientific innovation and industrial applications, offering a glimpse into the profound implications it holds for various sectors. As we delve into the intricacies of the Global T7 RNA Polymerase market, it becomes apparent that its significance extends beyond mere commercial transactions; it is a scientific realm that underpins advancements in biotechnology and molecular biology.

Get a Free Sample Report:https://www.metastatinsight.com/request-sample/2551

Who are the largest manufacturers of the T7 RNA Polymerase Market

worldwide?

Hongene Biotech Corporation

Kactus Biosystems

Novoprotein Scientific Inc.

Thermo Fisher Scientific Inc.

Yeasen Biotechnology (Shanghai) Co.,Ltd.

Tinzyme Co., Limited

New England Biolabs

Canvax Reagents SL

Merck KGaA

Hzymes Biotech

T7 RNA Polymerase, a key player in this market, stands as a catalyzing agent for transcriptional processes. Its pivotal role lies in its ability to initiate RNA synthesis from a DNA template, a fundamental step in the synthesis of RNA molecules. This enzymatic prowess has positioned T7 RNA Polymerase at the forefront of gene expression studies, rendering it indispensable for researchers and scientists navigating the complex landscape of molecular biology.

Access Full Report @https://www.metastatinsight.com/report/t7-rna-polymerase-market

The market's landscape is not static but ever evolving, mirroring the relentless march of scientific progress. From research laboratories to industrial applications, the Global T7 RNA Polymerase market finds itself embedded in diverse contexts. Laboratories across the globe leverage T7 RNA Polymerase for gene cloning, expression profiling, and the production of RNA transcripts for various experiments. Its utility extends to the synthesis of RNA probes for in situ hybridization, a technique that has become indispensable in visualizing gene expression patterns within cells.

Environmental research, too, embraces the versatility of T7 RNA Polymerase. Its application in studying microbial communities and their response to environmental changes underscores its significance in unraveling ecological intricacies. The market, therefore, emerges not merely as a commercial entity but as a cornerstone of scientific progress with far-reaching implications for humanity’s understanding of life processes.

The Global T7 RNA Polymerase market is not a static entity defined by growth factors but a dynamic force shaping the contours of scientific exploration and industrial applications. Its significance reverberates through laboratories, industries, and research institutions, contributing to advancements that resonate across diverse domains. The journey of T7 RNA Polymerase from a molecular player to a transformative force in various sectors epitomizes the intricate interplay between science and industry, underscoring the profound impact it continues to have on our understanding of biology and the technological landscape.

Global T7 RNA Polymerase market is estimated to reach $128.6 Million by 2031; growing at a CAGR of 11.0% from 2024 to 2031.

Contact Us:   

inquiry@metastatinsight.com

+1 214 613 5758